GammaTile Therapy
Education
Learn more about GammaTile Therapy
We invite you to browse through the videos, read the FAQs, and take a deep dive into the science behind GammaTile Therapy by watching the webinars and reading the clinical publications.
Note: In January 2020, GammaTile Therapy was FDA cleared for the treatment of newly diagnosed malignant brain tumors of all types in addition to the existing clearance for recurrent brain tumors.
GammaTile in the Media
WeTV | March 21, 2020 | New approach for the treatment of brain tumors on the lifestyle list
North Carolina CBS | January 24, 2020 | Vidant Health™ and the ECU Brody School of Medicine successfully perform the first-in-state GammaTile procedure
Cronkite News Division of Arizona PBS | Oct 22, 2019 | Battling brain tumors with time-released radiation
Arizona CBS | August 14, 2019 | New therapy to slow down brain tumors forever changes Arizona woman's life
Florida NBC | March 20, 2020 | GammaTile: New approach for the treatment of brain tumors
Ohio CBS | November 7, 2019 | New brain cancer therapy provides radiation right at site of tumor
Ohio CBS | August 20, 2019 | Mayfield Brain and Spine neurosurgeon using new radiation therapy
Minnesota CBS | February 14, 2019 | New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega
March 18, 2020 | Physician Perspective on GammaTile Therapy | Dr. McCracken, a neurosurgeon at Piedmont Atlanta Hospital
August 14, 2019 | Physician Perspective on GammaTile Therapy | Dr Clark Chen, a neurosurgeon at University of Minnesota Health
Physician Perspectives
Founder Interview | October 1, 2018 |
Introducing GammaTile Therapy
FAQs
Below are the answers to important questions about GammaTile Therapy. Speak with your treatment team to see if GammaTile Therapy is right for you or your loved one.
Webinars
American Brain Tumor Association | February 27, 2020
Webinar: Therapies Given During Surgery
This webinar provides a detailed overview of surgically implanted brain tumor therapies, including GammaTile Surgically Targeted Radiation Therapy (STaRT). Dr John A. Boockvar, the director of the Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill, discusses various treatment options, highlights their differences, and provides guidance on how patients can talk with their heath team about their care plan.
2019 Brain Tumor Webinar Series | May 26, 2019
Webinar: GammaTiles for Brain Tumors
Watch an in-depth educational webinar about GammaTile Therapy, presented by world-renowned neurosurgeon Dr Joseph Zabramski and hosted by The Musella Foundation. Content includes background, safety and efficacy, surgical placement, a case study, and clinical trial information.
Clinical Publications
CURRENT ONCOLOGY REPORTS 2020
Evolving strategies to potentially further optimize surgical interventions in brain cancer
Bindi B. Parikh, MD and Elizabeth C. Neil, MD, in Current Oncology Reports. 2020; 22, 32. Read here
JOURNAL OF NEUROSURGERY 2019
Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas
David G. Brachman, MD, Emad Youssef, MD, Christopher J. Dardis, MD, Nader Sanai, MD, Joseph M. Zabramski, MD, Kris A. Smith, MD, Andrew S. Little, MD, Andrew G. Shetter, MD, Theresa Thomas, MS, Heyoung L. McBride, MD, MS, Stephen Sorensen, PhD, Robert F. Spetzler, MD, and Peter Nakaji, MDl, in the Journal of Neurosurgery. 2018;131:1683-1994.
doi:10.3171/2018.7.jns18656. Read here
AANS ANNUAL SCIENTIFIC MEETINGS 2019 – 2020
Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial
Peter Nakaji, MD, FAANS; Emad Youssef, MD; Christopher Dardis, MD; Kris Smith, MD; Dilini Pinnaduwage, PhD; David Brachman, MD, at the 2019 AANS Meeting. Read here
Vincent Anthony DiNapoli, MD, Yair Gozal, MD, PhD, at the 2020 AANS Meeting. Read here
AMERICAN BRACHYTHERAPY SOCIETY ANNUAL MEETING 2019
Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial.
David Brachman, MD, Emad Youssef, MD, Christopher Dardis, MD, Kris Smith, MD, Dilini Pinnaduwage, PhD, Peter Nakaji, MD, in Brachytherapy. 2019;18(3):S35-S36. doi: 10.1016/j.brachy.2019.04.076. Read here
SNO ANNUAL MEETING 2019
RTHP-32. First experience with GammaTile permanent implants for recurrent brain tumors
Clara Ferreira, Parham Alaei, Clark Chen, Margaret Reynolds, David Sterling, Kathryn Dusenbery, in Neuro-Oncology. 2019;21 (Supplement_6):vi216. doi:10.1093/neuonc/noz175.903. Read here
REFERENCES
-
Nakaji P, Youssef E, Dardis C, Smith K, Pinnaduwage D, Brachman D. Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms. Poster presented at: 2019 AANS Annual Scientific Meeting; April 2019; San Diego, CA.
-
Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: Safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35-S36.